跳至主要内容
临床试验/NCT05298826
NCT05298826已完成不适用

Recombinant Factor VII for the Conservative Management Trials of Intractable Postpartum Haemorrhage: is it a Drug Effect , Operator Experience or Inherent Result of the Aetiology.

Aljazeera Hospital1 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2019年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
41
试验地点
1
主要终点
The number of women who had hysterectomy

研究概览

简要总结

Postpartum haemorrhage remains at the top of the causes of maternal deaths in both developed and developing countries .

详细描述

Major postpartum haemorrhage is a dangerous complication that accounts for the highest maternal morbidity rate

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with severe resistant postpartum hemorage

排除标准

  • women without postpartum hemorage

研究组 & 干预措施

Junior staff has started the management and called for the senior staff.

干预措施: recombinant factor VIIa (Drug)

senior staff. managed the case from the start

干预措施: recombinant factor VIIa (Drug)

结局指标

主要结局

The number of women who had hysterectomy

时间窗: 24 hours

number of women resistant to the treatment and needed hysterectomy

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验